Penumbra, Inc. PEN
319.11 USD -1.51 (-0.47%)
Regular-session close
319.11 0.00 0.00%
After hours · Nov 17, 6:06 PM ET
319.06 Day range 320.60
276.01 52-week range 362.41
- YTD
- +2.64%
- 1 year
- +14.58%
News
benzinga.com Penumbra Q3 EPS $1.07 Misses $1.25 Estimate, Sales $410.145M Beat $403.345M Estimate Penumbra (NYSE:PEN) reported quarterly earnings of $1.07 per share which missed the analyst consensus estimate of $1.25 by 14.4 percent. This is a 10.31 percent increase over earnings of $0.97 per…
prnewswire.com Penumbra, Inc. Reports Third Quarter 2026 Financial Results ALAMEDA, Calif., Oct. 29, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2026.benzinga.com Penumbra Wins FDA Clearance For Lightning CAVT Technology To Treat Deep Vein Thrombosis, Backed By BOLT-DVT Trial Results BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, demonstrated first-line use of computer assisted vacuum thrombectomy (CAVT) for DVT is safe and…
prnewswire.com Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT) BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, demonstrated first-line use of computer assisted vacuum thrombectomy (CAVT) for DVT is safe and effective…
defenseworld.net Penumbra (NYSE:PEN) Stock Breaks Above 50-Day Moving Average – Should You Sell? Penumbra, Inc. (NYSE: PEN - Get Free Report)'s share price passed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $321.17 and traded as high…
prnewswire.com New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and anticoagulation alone translate to patients' everyday recovery ALAMEDA,…
zacks.com IART vs. PEN: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integra LifeSciences (IART) and Penumbra (PEN). But which of these two stocks offers value…
defenseworld.net Penumbra (NYSE:PEN) Stock Price Breaks Below Fifty Day Moving Average – What’s Next? Penumbra, Inc. (NYSE: PEN - Get Free Report)'s stock price crossed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $321.74 and traded as low as…
zacks.com IART or PEN: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integra LifeSciences (IART) and Penumbra (PEN). But which of these two companies is the best option…
zacks.com Reasons to Retain Penumbra Stock in Your Portfolio for Now PEN's portfolio expansion and international growth support momentum, while rising costs, FX exposure and margin pressure remain key risks.
zacks.com TFX vs. PEN: Which Stock Is the Better Value Option? Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks is more attractive to value investors?
defenseworld.net Connor Clark & Lunn Investment Management Ltd. Buys New Position in Penumbra, Inc. $PEN Connor Clark and Lunn Investment Management Ltd. purchased a new position in shares of Penumbra, Inc. (NYSE: PEN) during the second quarter, according to its most recent 13F filing with the…
zacks.com TFX or PEN: Which Is the Better Value Stock Right Now? Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued…
zacks.com TFX vs. PEN: Which Stock Is the Better Value Option? Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity…
prnewswire.com Penumbra, Inc. Reports Second Quarter 2026 Financial Results ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026.
defenseworld.net Bank of Nova Scotia Acquires 210,402 Shares of Penumbra, Inc. $PEN Bank of Nova Scotia boosted its stake in Penumbra, Inc. (NYSE: PEN) by 14,837.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission…
defenseworld.net California Public Employees Retirement System Increases Position in Penumbra, Inc. $PEN California Public Employees Retirement System lifted its stake in shares of Penumbra, Inc. (NYSE: PEN) by 25.1% during the undefined quarter, according to the company in its most recent filing with…
gurufocus.com THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care PR Newswire ALAMEDA, Cal
prnewswire.com THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care First and only CAVT device for stroke demonstrated high revascularization rates, short procedure times and low complication rates ALAMEDA, Calif., July 22, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE:…
defenseworld.net Penumbra, Inc. $PEN Shares Sold by Bank of New York Mellon Corp Bank of New York Mellon Corp decreased its stake in shares of Penumbra, Inc. (NYSE: PEN) by 0.9% during the undefined quarter, according to the company in its most recent filing with the Securities…
marketbeat.com 3 Medical Device Stocks Giving Investors a Different Healthcare Play When investors think of the health care sector, most imagine the stability of pharmaceutical giants or the high-risk/high-reward profile of up-and-coming clinical stage drug developers. Medical…
zacks.com IQV vs. PEN: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical - Instruments sector have probably already heard of IQVIA Holdings (IQV) and Penumbra (PEN). But which of these two stocks is more attractive to value…
